273 related articles for article (PubMed ID: 25891352)
1. Nicotinamide adenine dinucleotide: An essential factor in preserving hearing in cisplatin-induced ototoxicity.
Kim HJ; Oh GS; Shen A; Lee SB; Khadka D; Pandit A; Shim H; Yang SH; Cho EY; Song J; Kwak TH; Choe SK; Park R; So HS
Hear Res; 2015 Aug; 326():30-9. PubMed ID: 25891352
[TBL] [Abstract][Full Text] [Related]
2. Dunnione ameliorates cisplatin ototoxicity through modulation of NAD(+) metabolism.
Kim HJ; Pandit A; Oh GS; Shen A; Lee SB; Khadka D; Lee S; Shim H; Yang SH; Cho EY; Kwak TH; Choe SK; Park R; So HS
Hear Res; 2016 Mar; 333():235-246. PubMed ID: 26341473
[TBL] [Abstract][Full Text] [Related]
3. Augmentation of NAD(+) by NQO1 attenuates cisplatin-mediated hearing impairment.
Kim HJ; Oh GS; Shen A; Lee SB; Choe SK; Kwon KB; Lee S; Seo KS; Kwak TH; Park R; So HS
Cell Death Dis; 2014 Jun; 5(6):e1292. PubMed ID: 24922076
[TBL] [Abstract][Full Text] [Related]
4. New Therapeutic Concept of NAD Redox Balance for Cisplatin Nephrotoxicity.
Oh GS; Kim HJ; Shen A; Lee SB; Yang SH; Shim H; Cho EY; Kwon KB; Kwak TH; So HS
Biomed Res Int; 2016; 2016():4048390. PubMed ID: 26881219
[TBL] [Abstract][Full Text] [Related]
5. Modulation of NAD
Zhan T; Xiong H; Pang J; Zhang W; Ye Y; Liang Z; Huang X; He F; Jian B; He W; Gao Y; Min X; Zheng Y; Yang H
Toxicol Lett; 2021 Oct; 349():115-123. PubMed ID: 34089817
[TBL] [Abstract][Full Text] [Related]
6. Dunnione ameliorates cisplatin-induced small intestinal damage by modulating NAD(+) metabolism.
Pandit A; Kim HJ; Oh GS; Shen A; Lee SB; Khadka D; Lee S; Shim H; Yang SH; Cho EY; Kwon KB; Kwak TH; Choe SK; Park R; So HS
Biochem Biophys Res Commun; 2015 Nov; 467(4):697-703. PubMed ID: 26498527
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin-Induced Ototoxicity: Updates on Molecular Targets.
Gentilin E; Simoni E; Candito M; Cazzador D; Astolfi L
Trends Mol Med; 2019 Dec; 25(12):1123-1132. PubMed ID: 31473143
[TBL] [Abstract][Full Text] [Related]
8. A reduced form of nicotinamide riboside protects the cochlea against aminoglycoside-induced ototoxicity by SIRT1 activation.
Fang J; Wu H; Zhang J; Mao S; Shi H; Yu D; Chen Z; Su K; Xing Y; Dong H; Shi H
Biomed Pharmacother; 2022 Jun; 150():113071. PubMed ID: 35658237
[TBL] [Abstract][Full Text] [Related]
9. COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss.
Crabb SJ; Martin K; Abab J; Ratcliffe I; Thornton R; Lineton B; Ellis M; Moody R; Stanton L; Galanopoulou A; Maishman T; Geldart T; Bayne M; Davies J; Lamb C; Popat S; Joffe JK; Nutting C; Chester J; Hartley A; Thomas G; Ottensmeier C; Huddart R; King E
Eur J Cancer; 2017 Dec; 87():75-83. PubMed ID: 29128692
[TBL] [Abstract][Full Text] [Related]
10. Protective role of edaravone against cisplatin-induced ototoxicity in an auditory cell line.
Im GJ; Chang J; Lee S; Choi J; Jung HH; Lee HM; Ryu SH; Park SK; Kim JH; Kim HJ
Hear Res; 2015 Dec; 330(Pt A):113-8. PubMed ID: 26278638
[TBL] [Abstract][Full Text] [Related]
11. Protective Effect of Avenanthramide-C on Auditory Hair Cells against Oxidative Stress, Inflammatory Cytokines, and DNA Damage in Cisplatin-Induced Ototoxicity.
Umugire A; Nam YS; Nam YE; Choi YM; Choi SM; Lee S; Cho JH; Cho HH
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769271
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies.
Tang Q; Wang X; Jin H; Mi Y; Liu L; Dong M; Chen Y; Zou Z
Eur J Pharm Biopharm; 2021 Jun; 163():60-71. PubMed ID: 33775853
[TBL] [Abstract][Full Text] [Related]
13. Strategies to reduce the risk of platinum containing antineoplastic drug-induced ototoxicity.
Mukherjea D; Dhukhwa A; Sapra A; Bhandari P; Woolford K; Franke J; Ramkumar V; Rybak L
Expert Opin Drug Metab Toxicol; 2020 Oct; 16(10):965-982. PubMed ID: 32757852
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of 1,2,3-triazole derivative KPR-A020 against cisplatin-induced ototoxicity in murine cochlear cultures.
Kim YR; Jung DJ; Oh SK; Lee T; Lee IK; Lee KY; Kim UK
Int J Pediatr Otorhinolaryngol; 2017 May; 96():59-64. PubMed ID: 28390615
[TBL] [Abstract][Full Text] [Related]
15. Puerarin inhibits cisplatin-induced ototoxicity in mice through regulation of TRPV1-dependent calcium overload.
Lin Y; Liang R; Xie K; Ma T; Zhang J; Xu T; Wang A; Liu S
Biochem Pharmacol; 2024 Feb; 220():115962. PubMed ID: 38043717
[TBL] [Abstract][Full Text] [Related]
16. Future opportunities in preventing cisplatin induced ototoxicity.
van den Berg JH; Beijnen JH; Balm AJ; Schellens JH
Cancer Treat Rev; 2006 Aug; 32(5):390-7. PubMed ID: 16781082
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Gpx4-mediated ferroptosis alleviates cisplatin-induced hearing loss in C57BL/6 mice.
Liu Z; Zhang H; Hong G; Bi X; Hu J; Zhang T; An Y; Guo N; Dong F; Xiao Y; Li W; Zhao X; Chu B; Guo S; Zhang X; Chai R; Fu X
Mol Ther; 2024 May; 32(5):1387-1406. PubMed ID: 38414247
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention.
Schacht J; Talaska AE; Rybak LP
Anat Rec (Hoboken); 2012 Nov; 295(11):1837-50. PubMed ID: 23045231
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of apocynin on cisplatin-induced ototoxicity in an auditory cell line and in zebrafish.
Choi J; Im GJ; Chang J; Chae SW; Lee SH; Kwon SY; Chung AY; Park HC; Jung HH
J Appl Toxicol; 2013 Feb; 33(2):125-33. PubMed ID: 22147442
[TBL] [Abstract][Full Text] [Related]
20. A novel synthetic compound, 3-amino-3-(4-fluoro-phenyl)-1H-quinoline-2,4-dione, inhibits cisplatin-induced hearing loss by the suppression of reactive oxygen species: in vitro and in vivo study.
Shin YS; Song SJ; Kang SU; Hwang HS; Choi JW; Lee BH; Jung YS; Kim CH
Neuroscience; 2013 Mar; 232():1-12. PubMed ID: 23246618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
